Alert B&C Corporation announces the conclusion of its non-brokered private placement unit financing


    CALGARY, July 16 /CNW Telbec/ - ALERT B&C Corporation ("ALERT B&C" or the
"Corporation") (TSX Venture Exchange: ACB) is pleased to announce the
conclusion of the Non-Brokered Private Placement announced on May 20, 2009.
    The Corporation issued a total of 300 Units at a price of $1,000 per unit
for total gross proceeds of $300,000.00. Each Unit will consist of a $1,000
principal amount of 10 percent secured convertible debentures (the
"Debentures") and 10,000 common share purchase warrants (the "Warrants"), each
whole warrant entitling the holder to acquire one common share of ALERT B&C at
a price of $0.10 per share for a period of 36 months from closing. The common
shares issuable upon the conversion of the Debentures and/or exercising of the
Warrants will be subject to a four-month hold period in all of the offering
jurisdictions, ending October 12, 2009.
    The net proceeds will be used for general corporate purposes and working
capital. Use of proceeds may also include costs associated with application
and business development.
    The Corporation has taken major steps to reduce the burn rate to minimal
levels, and will use these funds to explore several business opportunities.
The Corporation is currently evaluating a number of strategic initiatives to
maximize shareholder value and expects positive negotiations through the
pursuit of these initiatives.

    About ALERT B&C Corporation

    The Corporation is a BioDefence company dedicated to supplying the
BioDefence market with high quality technologies, products and solutions, in
order to improve and maintain the safety and the security of individuals
worldwide. The Intellectual Property owned by ALERT B&C, the MAB Technology
has been in use since 2001 by a variety of groups and is a globally recognized
technology. For more information about the Corporation visit our new website
at www.alertbiochem.com.

    This press release contains forward-looking statements, which reflect the
Corporation's current expectations regarding future events. The
forward-looking statements involve risks and uncertainties. Actual events
could differ materially from those projected herein. Investors should consult
the Corporation's quarterly filings and annual reports for additional
information on risks and uncertainties relating to these forward-looking
statements. The reader is cautioned not to rely on these forward-looking
statements. The Corporation disclaims any obligation to update these
forward-looking statements.The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this press release.%SEDAR: 00012523E



For further information: Mr. Kurt G.J. Soost, President & CEO, ALERT B&C
Corporation, (403) 802-0366, 1-866-802-0366 (Canada), Fax: (403) 802-0766,
ksoost@alertbiochem.com